Loading
Latest filing published 13 Nov 2008 for SCOLR Pharma, Inc., €2,143.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Alan M. Mitchel in SCOLR Pharma, Inc. Between 20 March 2007 and 12 November 2008, the trades on record add up to 8 filings.
Every open-market trade on record is a purchase: 7 purchases worth €13k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2008: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €2,091.
The newest entry dates from 13 November 2008: an open-market purchase of €2,143, in SCOLR Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations